Royal London Asset Management
CMD

Royal London Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Royal London Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-148,995
Closed -$9.97M – 655
2019
Q1 		$9.97M Buy
148,995
+43,105
+41% +$3.26M 0.08% 251
2018
Q4 		$7.89M Buy
105,890
+80,308
+314% +$6.63M 0.07% 291
2018
Q3 		$2.35M Buy
25,582
+14,088
+123% +$1.34M 0.02% 462
2018
Q2 		$1.13M Buy
+11,494
New +$1.29M 0.01% 555

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Royal London Asset Management's CMD Position: Q2 2019 in Review

Royal London Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 148,995 shares — an estimated $9.97M sold.

Royal London Asset Management first reported a position in CMD in Q2 2018 and held it in 4 quarters. The position peaked at $9.97M in Q1 2019. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Royal London Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Royal London Asset Management sold 148,995 Cantel Medical Corporation shares in Q2 2019, an estimated $9.97M.
  • Royal London Asset Management first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 4 quarters.
  • Royal London Asset Management's Cantel Medical Corporation position peaked at $9.97M in Q1 2019.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Royal London Asset Management's 13F filing for Q2 2019, filed 31 Jul 2019.